Topical 5-aminolaevulinic acid photodynamic therapy for the treatment of skin conditions other than non-melanoma skin cancer (Q34570370)

3 August 2017

1 reference

title

Topical 5-aminolaevulinic acid photodynamic therapy for the treatment of skin conditions other than non-melanoma skin cancer (English)

1 reference

3 August 2017

Ibbotson SH

1

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

British Journal of Dermatology

3 August 2017

published in

1 reference

3 August 2017

volume

146

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

178-188

1 reference

Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-amino levulinic acid sensitization and laser irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

Topical photodynamic therapy in verrucae. A pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

Recalcitrant hand and foot warts successfully treated with photodynamic therapy with topical 5-aminolaevulinic acid: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

Photodynamic therapy with topical delta-aminolaevulinic acid for the treatment of plantar warts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

An action spectrum for blue and near ultraviolet inactivation of Propionibacterium acnes; with emphasis on a possible porphyrin photosensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

Singlet oxygen (1 delta g) generation from coproporphyrin in Propionibacterium acnes on irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

Topical ALA-photodynamic therapy for the treatment of acne vulgaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

Photodynamic therapy of acne vulgaris with topical delta-aminolaevulinic acid and incoherent light in Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

Response of psoriasis to red laser light (630 nm) following systemic injection of hematoporphyrin derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

The accumulation of protoporphyrin IX in plaque psoriasis after topical application of 5-aminolevulinic acid indicates a potential for superficial photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

The variable response of plaque psoriasis after a single treatment with topical 5-aminolaevulinic acid photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

Optimum porphyrin accumulation in epithelial skin tumours and psoriatic lesions after topical application of delta-aminolaevulinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

Improved response of plaque psoriasis after multiple treatments with topical 5-aminolaevulinic acid photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

Inactivation of erythrocytic, lymphocytic and myelocytic leukemic cells by photoexcitation of endogenous porphyrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

Large mutagenic lesions are induced by photodynamic therapy in murine L5178Y lymphoblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

Photodynamic therapy of cutaneous lymphoma using 5-aminolevulinic acid topical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

Photodynamic therapy utilising topical delta-aminolevulinic acid in non-melanoma skin malignancies of the eyelid and the periocular skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

Topical 5-aminolaevulinic acid photodynamic therapy for tumour-stage mycosis fungoides

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

Photodynamic therapy with topical 5-aminolevulinic acid for mycosis fungoides: clinical and histological response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

Photodynamic therapy for residual neoplasms of the perianal skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

Selective photosensitizer distribution in vulvar condyloma acuminatum after topical application of 5-aminolevulinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

Epidermodysplasia verruciformis treated using topical 5-aminolaevulinic acid photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

Single-episode photodynamic therapy and vulval intraepithelial neoplasia type III resistant to conventional therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

Photodynamic therapy of vulvar intraepithelial neoplasia using 5-aminolevulinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

Photodynamic therapy of vulvar intraepithelial neoplasia III using topically applied 5-aminolevulinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

In vivo kinetics and spectra of 5-aminolaevulinic acid-induced fluorescence in an amelanotic melanoma of the hamster

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

In vivo fluorescence kinetics and photodynamic therapy using 5-aminolaevulinic acid-induced porphyrin: increased damage after multiple irradiations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

Topical and intratumoral photodynamic therapy with 5-aminolevulinic acid in a subcutaneous murine mammary adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

Photodynamic therapy of cutaneous metastases of breast cancer after local application of meso-tetra-(para-sulphophenyl)-porphin (TPPS4).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-0963.2001.04689.X

10.1046/J.0007-0963.2001.04689.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference